What are Collegium Pharmaceutical, Inc.'s profit margins?

Collegium Pharmaceutical, Inc. (COLL) runs a 60.7% gross margin and a 23.7% operating margin, with a 9.4% net margin.

Where do Collegium Pharmaceutical, Inc.'s ratios come from?

Every ratio is computed from Collegium Pharmaceutical, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Collegium Pharmaceutical, Inc. COLL Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	59.3%-0.4pp	59.8%+2.2pp	57.5%+12.4pp	45.2%-9.2pp
Operating margin	23%-3.9pp	26.9%-2.6pp	29.5%+22.3pp	7.2%+0.8pp
Net margin	8.1%-2.9pp	11%+2.5pp	8.5%+13.9pp	-5.4%-31.2pp
EBITDA margin	30.7%-23.0pp	53.7%-2.1pp	55.8%+27.8pp	28%-3.2pp
Free cash flow margin	42%+8.3pp	33.7%-14.7pp	48.4%+22.0pp	26.4%-10.3pp
Returns
Return on equity	23.7%-8.9pp	32.6%+7.9pp	24.7%+37.2pp	-12.6%-49.3pp
Return on assets	3.8%-1.1pp	4.9%+0.8pp	4.2%+6.8pp	-2.7%-13.4pp
Return on invested capital	125.6%—	——	——	121.9%+46.4pp
Efficiency
Asset turnover	0.5×0.0×	0.4×0.0×	0.5×0.0×	0.5×+0.1×
Inventory turnover	12.8×+5.3×	7.5×+1.4×	6.1×-1.9×	8×+0.3×
Liquidity
Current ratio	1.6×+0.6×	0.9×-0.2×	1.2×+0.2×	1×-0.2×
Quick ratio	1.5×+0.7×	0.9×-0.2×	1.1×+0.2×	0.9×-0.2×
Cash ratio	0.6×+0.4×	0.2×-0.3×	0.5×+0.1×	0.4×-0.3×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-1×-0.8×	-0.3×+0.5×	-0.7×+0.5×	-1.3×+0.8×
Interest coverage	2.2×-0.1×	2.3×+0.3×	2×+1.5×	0.5×-0.3×
Per Share
Book value per share	$7.53+31.9%	$5.71+20.5%	$4.73-18.4%	$5.80-2.4%
Valuation
Market capitalization	$1.15B+17.9%	$923.97M-7.9%	$1B+28.9%	$778.87M+20.6%
Enterprise value	$869.67M-0.3%	$834.17M+8.1%	$771.93M+25.8%	$613.4M+31.0%
Price / earnings	15.4×-6.9×	13.4×-7.5×	20.8×—	——
Price / sales	1.5×0.0×	1.5×-0.3×	1.8×+0.1×	1.7×-0.7×
Price / book	3.6×-0.5×	4×-1.1×	5.1×+1.1×	4×+0.8×
EV / EBITDA	3.4×+0.9×	2.5×0.0×	2.4×-2.3×	4.7×-0.7×
EV / sales	1.1×-0.2×	1.3×0.0×	1.4×0.0×	1.3×-0.4×
Free cash flow yield	29.2%+7.7pp	23%-4.3pp	27.3%+11.6pp	15.7%0.0pp
Earnings yield	6.6%+2.1pp	7.5%+2.7pp	4.8%+8.0pp	-3.2%-14.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Collegium Pharmaceutical, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Collegium Pharmaceutical, Inc.'s profit margins?: Collegium Pharmaceutical, Inc. (COLL) runs a 60.7% gross margin and a 23.7% operating margin, with a 9.4% net margin.
Where do Collegium Pharmaceutical, Inc.'s ratios come from?: Every ratio is computed from Collegium Pharmaceutical, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.